Adicet Bio Inc reports results for the quarter ended in December - Earnings Summary

ADICET Bio

15/03/2023 20:29

* Adicet Bio Inc  ACET.OQ  reported a quarterly adjusted
loss
of 72 cents​​ per share for the quarter ended in December. The
mean expectation of ten analysts for the quarter was for a loss
of 28 cents per share.
    * Reported revenue was zero​; analysts expected $11.56
million. 
    * Adicet Bio Inc's reported EPS for the quarter was a loss
of 72
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Adicet Bio Inc shares had fallen by 11.0% this quarter.
    * The company reported a quarterly loss of $29.88 million.
    * Wall Street's median 12-month price target for Adicet Bio
Inc is
$27.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 15 at 08:29 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.28          -0.72          Missed
 Sep. 30 2022      -0.53          -0.53          Met
 Jun. 30 2022      -0.45          -0.56          Missed
 Mar. 31 2022      -0.18          0.10           Beat